Back to Search

GEROLD BEPLER, MD

MD

Medical Oncology Physician

NPI: 1447280631Individual

Specialties, Licenses & Credentials

Medical Oncology PhysicianPrimary

Internal Medicine — Medical Oncology

Code: 207RX0202X

ME86830(FL)4301097639(MI)

Research & Publications (20)

What can interest tell us about uptake of genetic testing? Intention and behavior amongst smokers related to patients with lung cancer.
PMID 19556750·Public Health Genomics·2010
4-observational
High expression of mammalian target of rapamycin is associated with better outcome for patients with early stage lung adenocarcinoma.
PMID 19509151·Clin Cancer Res·2009
8-other
Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma.
PMID 19543324·Oncogene·2009
8-other
Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinoma.
PMID 19064983·J Clin Oncol·2009
8-other
Responses to online GSTM1 genetic test results among smokers related to patients with lung cancer: a pilot study.
PMID 19567511·Cancer Epidemiol Biomarkers Prev·2009
8-other
Rupture of a cerebral arteriovenous malformation in a patient treated with bevacizumab.
PMID 19179909·J Thorac Oncol·2009
5-case
Mirk/Dyrk1B, a novel therapeutic target, mediates cell survival in non-small cell lung cancer cells.
PMID 19633423·Cancer Biol Ther·2009
7-preclinical
Persistent smoking after a diagnosis of lung cancer is associated with higher reported pain levels.
PMID 19254679·J Pain·2009
8-other
Treatment success in cancer: new cancer treatment successes identified in phase 3 randomized controlled trials conducted by the National Cancer Institute-sponsored cooperative oncology groups, 1955 to 2006.
PMID 18362256·Arch Intern Med·2008
8-other
Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis.
PMID 18309950·J Clin Oncol·2008
1-meta
Computed tomography response, but not positron emission tomography scan response, predicts survival after neoadjuvant chemotherapy for resectable non-small-cell lung cancer.
PMID 18824709·J Clin Oncol·2008
3-trial
Clinical efficacy and predictive molecular markers of neoadjuvant gemcitabine and pemetrexed in resectable non-small cell lung cancer.
PMID 18827606·J Thorac Oncol·2008
3-trial
Molecular analysis-based treatment strategies for non-small cell lung cancer.
PMID 18376380·Cancer Control·2008
8-other
Beta-carotene in multivitamins and the possible risk of lung cancer among smokers versus former smokers: a meta-analysis and evaluation of national brands.
PMID 18429004·Cancer·2008
1-meta
Thymidylate synthase in situ protein expression and survival in stage I nonsmall-cell lung cancer.
PMID 18442042·Cancer·2008
8-other
Proteomic contributions to personalized cancer care.
PMID 18664563·Mol Cell Proteomics·2008
6-review
Enzastaurin, an oral serine/threonine kinase inhibitor, as second- or third-line therapy of non-small-cell lung cancer.
PMID 18309949·J Clin Oncol·2008
3-trial
A message of hope: creation of the Faces of Lung Cancer project for increasing awareness of clinical trials.
PMID 18771536·Eur J Cancer Care (Engl)·2008
8-other
Non-small cell lung cancer.
PMID 18377844·J Natl Compr Canc Netw·2008
6-review
Phase I/II study of atrasentan, an endothelin A receptor antagonist, in combination with paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer.
PMID 18316570·Clin Cancer Res·2008
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
4100 JOHN R
DETROIT, MI 48201

Location

Practice Location

4100 JOHN R, DETROIT, MI
(800) 527-6266

Quick Facts

NPI
1447280631
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
2
Locations
1
Publications
20

Are you this provider?

Claim Your Profile